Savient’s Liquid Tamoxifen Soltamox Gets FDA Approval
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm is seeking potential partners to market the first oral solution formulation of the breast cancer drug.
You may also be interested in...
Liquid Tamoxifen To Be Launched By Cytogen In Third Quarter
Cytogen signs an exclusive distribution agreement with manufacturer Savient.
Actelion CEO Jean-Paul Clozel: An Interview With “The Pink Sheet” DAILY (Part 2 of 2)
CEO Clozel discusses the firm’s renin inhibitor program in the face of Novartis’ Tekturna, alliances with Merck and Roche and its business strategy going forward.